| Trial ID: | L2024 |
| Source ID: | NCT01794091
|
| Associated Drug: |
Eplerenone
|
| Title: |
Detection of Diffuse Scar in Patients With Diabetes
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type II
|
| Interventions: |
DRUG: Eplerenone|DRUG: Placebo
|
| Outcome Measures: |
Primary: All cause mortality, cardiovascular death, myocardial infarction or stroke, 5 years |
|
| Sponsor/Collaborators: |
Sponsor: Brigham and Women's Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING
|
| Start Date: |
2013-08
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2013-02-18
|
| Locations: |
Brigham and Women's Hospital, Boston, Massachusetts, 02114, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01794091
|
